Methotrexate
Methotrexate is a folate antagonist used in oncology and autoimmune disease management including leukemia, rheumatoid arthritis, and psoriasis.
Detailed technical, regulatory, and supply information is available for commercial evaluation.
Technical Overview
Methotrexate – CAS 59-05-2
CAS Number
59-05-2
Category
Oncology
Therapeutic Class
Antineoplastic / Antimetabolite
Description
Methotrexate is a folate antagonist used in oncology and autoimmune disease management including leukemia, rheumatoid arthritis, and psoriasis.
Applications
- Acute lymphoblastic leukemia
- Breast cancer
- Rheumatoid arthritis
- Psoriasis
Handling & Supply Details
Packaging
Standard export packaging in double-lined HDPE drums or fiber drums with inner poly liners; custom pack sizes available on request.
Product Inquiry
Disclaimer
Products offered are intended strictly for R&D, registration and/or export purposes only. The responsibility for ensuring that the product does not infringe any third-party patent or intellectual property rights in the destination country rests solely with the buyer.